LY-2157299

transforming growth factor alpha ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32597324 Computational modeling of transforming growth factor β and activin a receptor complex formation in the context of promiscuous signaling regulation. 2021 Sep 1
2 33268571 A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma. 2021 Feb 1
3 33628309 Punicalin Alleviates OGD/R-Triggered Cell Injury via TGF-β-Mediated Oxidative Stress and Cell Cycle in Neuroblastoma Cells SH-SY5Y. 2021 2
4 34253166 Downregulation of NKG2DLs by TGF-β in human lung cancer cells. 2021 Jul 12 4
5 34298004 MicroRNA-495/TGF-β/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cells. 2021 Oct 1
6 34329782 Photothermal therapy mediated by gold nanocages composed of anti-PDL1 and galunisertib for improved synergistic immunotherapy in colorectal cancer. 2021 Oct 15 1
7 34440856 Radiation-Induced Overexpression of TGFβ and PODXL Contributes to Colorectal Cancer Cell Radioresistance through Enhanced Motility. 2021 Aug 13 1
8 34638842 Disulfiram Sensitizes a Therapeutic-Resistant Glioblastoma to the TGF-β Receptor Inhibitor. 2021 Sep 28 1
9 34884812 MT1-MMP Cooperates with TGF-β Receptor-Mediated Signaling to Trigger SNAIL and Induce Epithelial-to-Mesenchymal-like Transition in U87 Glioblastoma Cells. 2021 Nov 30 1
10 32532820 Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-β signaling and radioiodine resistance. 2020 Jul 31 1
11 32705856 Galunisertib enhances chimeric antigen receptor-modified T cell function. 2020 Jun 19 1
12 29866156 Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade. 2018 Jun 4 1